Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Digi International to Present at Canaccord Genuity Growth Conference
-
CalAmp To Present at the Canaccord Genuity Growth Conference on August 7
-
Arcimoto President and Founder Mark Frohnmayer to Address Canaccord Genuity Future of Transport Conference on August 6
-
X4 Pharmaceuticals to Attend Two Upcoming Investor Conferences
-
Telaria To Present at the Canaccord Genuity 39th Annual Growth Conference
-
STRATA Skin Sciences to Participate in Canaccord Genuity 39th Annual Growth Conference
-
Shockwave Medical to Participate in the 39th Annual Canaccord Genuity Global Growth Conference
-
Shockwave Medical to Participate in the 39th Annual Canaccord Genuity Global Growth Conference
-
AngioDynamics to Present at the Canaccord Genuity Growth Conference
-
Canaccord Genuity Group Inc. Access to First Quarter Fiscal 2020 Results Information
-
PlacementTracker Publishes Q2 2019 PIPE and Private Placement Markets League Tables
-
KULR Technology Group To Attend Canaccord Genuity Investor Conferences In August 2019
-
KULR Technology Group To Attend Canaccord Genuity Investor Conferences In August 2019
-
IPG Photonics to Participate in Upcoming Investor Conferences
-
SolarEdge Technologies (SEDG) PT Raised to $68 at Canaccord Genuity
-
BioXcel Therapeutics (BTAI) PT Raised to $24 at Canaccord Genuity
-
Acadia Pharmaceuticals (ACAD) PT Lowered to $25 at Canaccord Genuity
-
Gildan Activewear (GIL) PT Raised to $36 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on Quixant PLC ()
-
Canaccord Genuity Reiterates Buy Rating on PrairieSky Royalty Ltd (PREKF)
-
Canaccord Genuity Reiterates Spec. Buy Rating on Petropavlovsk ()
-
Air Canada (AC:CN) (ACDVF) PT Raised to Cdn$50 at Canaccord Genuity
-
BioXcel Therapeutics (BTAI) PT Raised to $24 at Canaccord Genuity
-
Digital Turbine to Participate in Upcoming Investor Conferences
-
Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Canaccord Genuity Downgrades TELUS Corp. (T:CN) (TU) to Hold
-
Canaccord Genuity Upgrades Shaw Communications (SJR/B:CN) (SJR) to Buy
-
DLH to Present at the Canaccord Genuity Conference on August 7
-
CPI Aerostructures to Participate at Upcoming Investor Conferences
-
Saracen Mineral Holdings Ltd. (SAR:AU) (SCEXF) PT Raised to AUD3.45 at Canaccord Genuity
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $80 at Canaccord Genuity
-
Cresco Labs Inc. (CL:CN) (CRLBF) PT Raised to Cdn$22 at Canaccord Genuity
-
Canaccord Genuity Starts Skyfii Ltd. (SKF:AU) at Buy
-
Columbia Care Announces Launch of Share Repurchase Program
-
Microsoft (MSFT) PT Raised to $155 at Canaccord Genuity
-
Intuitive Surgical (ISRG) PT Raised to $610 at Canaccord Genuity
-
Cinedigm Digital Cinema (CIDM) PT Lowered to $2.50 at Canaccord Genuity
-
ATARA Biotherapeutics (ATRA) Prices 6.87M Share Common Offering at $15.28/Sh
-
Atara Biotherapeutics Announces Pricing of $150.0 Million Public Offering
-
Atara Biotherapeutics Announces Pricing of $150.0 Million Public Offering
-
Canaccord Genuity Group Inc. Provides Outlook For First Quarter Fiscal 2020 Results
-
ATARA Biotherapeutics (ATRA) Announces Proposed $125M Share Common Offering
-
Aqua Metals Announces Schedule for its Second Quarter 2019 Results and Participation at Canaccord Genuity’s Growth Conference
-
Atara Biotherapeutics Announces Proposed Offering of Common Stock
-
Atara Biotherapeutics Announces Proposed Offering of Common Stock
-
Mogo to Participate in the Canaccord Genuity 39th Annual Growth Conference
-
Misonix to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8
-
Ducommun Announces Upcoming Investor Events
-
Forty Seven (FTSV) Prices 9.375M Share Common Offering at $8/Sh

